1. | the exploration of natural sources for small molecules, macromolecules and biochemical and genetic information that could be developed into commercially valuable products. |
2. | exploitation of a region's biological resources or indigenous knowledge unethically and without providing fair compensation. |
3. | the use of living organisms, like microbes and bacteria, in the removal of contaminants, pollutants, and toxins from soil, water, and other environments |
4. | the process of developing a crop with bioavailable micronutrients in its edible parts. |
1. | Only I is correct | 2. | Only II is correct |
3. | Both I and II are correct | 4. | Both I and II are incorrect |
1. | antigen-antibody interaction |
2. | radioactive probe tagging |
3. | culture of microbe in an artificial medium |
4. | histopathology |
1. | forms protein crystals during a particular phase of their growth which contains a toxic insecticidal protein. |
2. | The Bt toxin protein exists as an inactive protoxin that is converted into an active form by an alkaline pH in the insect's gut. |
3. | Activated toxin binds to the surface of midgut epithelial cells, creates pores, causes cell swelling and lysis and eventually death of the insect. |
4. | Proteins encoded by the genes cryIAc and cryIIAb control the corn borer, that of cryIAb controls cotton bollworms. |
I: | involves silencing of a specific mRNA due to a complementary dsRNA molecule that binds to and prevents translation of the mRNA (silencing). |
II: | has been used to create transgenic tobacco plants resistant to nematode Meloidogyne incognita |
1. | prepared two DNA sequences corresponding to A and B chains of human insulin and introduced them in plasmids of E. coli to produce insulin chains. |
2. | prepared two DNA sequences corresponding to A and C chains of human insulin and introduced them in plasmids of Yeast to produce insulin chains. |
3. | used reverse transcription of the hnRNA transcript of the insulin gene to make complementary DNA. |
4. | used fragments created by restriction enzyme digestion to isolate and used the gene for insulin from pancreatic cells. |
1. | Bone marrow transplant |
2. | Enzyme replacement therapy |
3. | Introduction of the gene isolated from marrow cells producing ADA at early embryonic stages. |
4. | Introduction of a functional ADA cDNA (using a retroviral vector) into peripheral lymphocytes. |
1. | α-1 antitrypsin is being produced in a transgenic sheep |
2. | The first transgenic cow, Rosie, produced human protein-enriched milk (2.4 grams per litre). |
3. | Transgenic mice are being used to test the safety of the polio vaccine. |
4. | Over 95 percent of all existing transgenic animals are cattle. |
1. | Genetic Engineering Approval Committee |
2. | Green Environment Action Committee |
3. | Genetic Engineering Appraisal Council |
4. | Genetic Ethics Approval Committee |